Effect of Traditional Ayurvedic Formulation Divya Cystogrit in patient with Cysts, Fibroids and Benign tumor.
- Conditions
- Health Condition 1: D3A8- Other benign neuroendocrine tumors
- Registration Number
- CTRI/2023/01/048769
- Lead Sponsor
- Patanjali Research Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
The age of the subject will be 18-70 years.
Subjects with a malignant tumor confirmed by histopathology or cytology.
Willing to participate and give consent for the study.
Capability for complete compliance and completion of follow-up.
Known allergy to any of the active ingredients or excipients of the study drug, or have a history of allergy to other opioids or NSAIDs and their related ingredients...
The subject with a known history of gastrointestinal bleeding or perforation, a positive result of fecal occult blood test during screening period, serious cardiovascular diseases, a history of an acute ischemic or hemorrhagic stroke within 6 months prior to screening, a history of significant psychiatric disorders, such as schizophrenia and depression.
History of alcohol abuse or drug abuse including opioids have significant opioid contraindications.
Expected pregnancy or breastfeeding.
The subject who is not willing to provide consent and comply with the protocol.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To observe the changes in quality of life in cancer patients taking Divya Cystogrit as per the treatment protocol by an ayurvedic practitioner.Timepoint: Baseline, Day 30, Day 60
- Secondary Outcome Measures
Name Time Method Changes in the Numeric Pain Rating Scale (NPRS), EORTC QOL C-30, Depression-Anxiety Stress Scale (DASS-21) and Medication Adherence Report Scale (MARS). <br/ ><br>Timepoint: Baseline, Day 30th and Day 60th